UMIN ID: UMIN000002854
Registered date:07/12/2009
Evaluation of efficacy of topical bromfenac (0.09%) as an adjunctive therapy for patients with neovascular age-related macular degeneration
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | exudative age-related macular degeneration |
| Date of first enrollment | 2009/11/01 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | topical bromfenac as an adjunctive therapy to intravitreal injection of ranibizumab topical artificail tears as the sham of blomfenac to intravitreal injection of ranibizumab |
Outcome(s)
| Primary Outcome | total number of injections of ranibizumab during 6 months' follow-up |
|---|---|
| Secondary Outcome | the rate of eyes with persistent leakage from choroidal neovascularization on fluorescein angiography |
Key inclusion & exclusion criteria
| Age minimum | 50years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | choroidal neovascularization secondary to pathorogical myopia or other diseases |
Related Information
| Primary Sponsor | Department of Ophthalmology, Osaka University Medical School |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Senju Pharmaceutical Co. LTD |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Fumi Gomi |
| Address | Japan |
| Telephone | 06-6879-3456 |
| fgomi@ophthal.med.osaka-u.ac.jp | |
| Affiliation | Osaka University Medical School Dept. of Ophthalmology |
| scientific contact | |
| Name | Fumi Gomi |
| Address | 2-2, Yamadaoka, Suita Japan |
| Telephone | |
| Affiliation | Osaka University Medical School Dept. of Ophthalmology |